Amniotics AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was SEK 2.28 million compared to SEK 0.351 million a year ago. Net loss was SEK 5.83 million compared to SEK 10.93 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0036 SEK | -2.70% | -7.69% | -60.00% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-60.00% | 908K | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- AMNI Stock
- News Amniotics AB
- Amniotics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023